![](https://investorshub.advfn.com/uicon/756069.png?cb=1605227140)
Monday, January 25, 2021 5:12:15 PM
If a company who just unblinded their data from a randomized controlled trial and had any concerns about those same trial results, they would NOT announce a collaboration with some obscure NASDAQ listed company who makes a drug for some obscure ailment. They would not "give" $1m away to do so, they would not "loan" $4m to be secured by a "lien on all of Acer's assets" either.
Now, if that same company wanted a fast track approach to be listed on the NASDAQ for "some reason", oh say that they just unblinded their data and it looks great, they would definitely do this. To me it seems quite clear what is about the occur but thinly veiled enough to blind some apparently.
Best,
JB
Disclaimer
All of my posts are just my own opinion and not advice to buy, sell or trade any stock, security or anything else for that matter. I post my own personal thoughts and information that I have found regarding positions that I am invested in.
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM